Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combined use of a sulfated glycosaminoglycan and a hyaluronidase for improving the bioavailability of factor VIII

Combined use of a sulfated glycosaminoglycan and a hyaluronidase for improving the bioavailability of factor VIII

US Patent 9511123 · Granted Dec 6, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Truncated von Willebrand Factor polypeptides for treating hemophilia2023
Pharmaceutical formulations of C1 esterase inhibitor2023
Method for improving the stability of purified Factor VIII after reconstitution2022
Method for improving the stability of purified Factor VIII after reconstitution2022
Protein purification and virus inactivation with alkyl glycosides2022
Method for improving the stability of purified Factor VIII after reconstitution2021
Method for improving the stability of purified Factor VIII after reconstitution2021
Truncated von Willebrand factor polypeptides for treating hemophilia2020
Method for improving the stability of purified factor VIII after reconstitution2020
Method for improving the stability of purified factor VIII after reconstitution2020
Factor VIII formulation2019
Sugar compositions for treating hemophilia A and/or Von Willebrand disease2019